IsomAb Appoints Dr Anker Lundemose as a Non-Executive Director Posted on April 16, 2024November 1, 2024 by edgover
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease Posted on February 20, 2024November 1, 2024 by edgover
